Factors associated with TBS worse than BMD in non-osteoporotic elderly population: Bushehr elderly health program.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
27 07 2021
Historique:
received: 25 01 2021
accepted: 02 07 2021
entrez: 28 7 2021
pubmed: 29 7 2021
medline: 10 8 2021
Statut: epublish

Résumé

Bone mineral density (BMD) and trabecular bone score (TBS) are moderately correlated. TBS is sometimes used as an adjuvant to BMD in the fracture risk assessment. Some individuals with normal BMD or osteopenia, have more degraded TBS. We aimed to identify factors associated with TBS worse than BMD in the non-osteoporotic elderly population. The study subjects were selected from 2384 women and men aged ≥60 years participating in the second stage of the Bushehr Elderly Health program, a population-based prospective cohort study in Iran. The BMDs of different sites and the lumbar spine texture were measured using dual-energy X-ray absorptiometry and the TBS algorithm, respectively. Subjects were categorized based on their BMD and TBS status. Logistic regression was performed to identify the factors associated with "TBS worse than BMD" in non-osteoporotic individuals. Of 1335 participants included in the study, 112 of 457 women, and 54 of 878 men had worse TBS than BMD. In multivariable analysis, TBS worse than BMD in women was statistically significantly associated with years since menopause (OR: 1.04 (1.00-1.07)) and waist circumference (OR: 1.09 (1.05-1.14)). However, in men, the condition was statistically significantly associated with waist circumference (OR: 1.10 (1.03-1.17)), current smoking (OR: 2.54 (1.10-5.84)), and HDL-C (OR: 1.03 (1.00-1.06)). The results of the study show that higher waist circumference is associated with more degraded TBS than BMD in both men and women. Years passed since menopause and current smoking, respectively in women and men, were associated with more degraded TBS. Considering TBS values in older individuals with higher waist circumference, or a history of smoking despite normal BMDs might help more accurate assessment of bone health. However, further studies are required to confirm the benefit.

Sections du résumé

BACKGROUND
Bone mineral density (BMD) and trabecular bone score (TBS) are moderately correlated. TBS is sometimes used as an adjuvant to BMD in the fracture risk assessment. Some individuals with normal BMD or osteopenia, have more degraded TBS. We aimed to identify factors associated with TBS worse than BMD in the non-osteoporotic elderly population.
METHODS
The study subjects were selected from 2384 women and men aged ≥60 years participating in the second stage of the Bushehr Elderly Health program, a population-based prospective cohort study in Iran. The BMDs of different sites and the lumbar spine texture were measured using dual-energy X-ray absorptiometry and the TBS algorithm, respectively. Subjects were categorized based on their BMD and TBS status. Logistic regression was performed to identify the factors associated with "TBS worse than BMD" in non-osteoporotic individuals.
RESULTS
Of 1335 participants included in the study, 112 of 457 women, and 54 of 878 men had worse TBS than BMD. In multivariable analysis, TBS worse than BMD in women was statistically significantly associated with years since menopause (OR: 1.04 (1.00-1.07)) and waist circumference (OR: 1.09 (1.05-1.14)). However, in men, the condition was statistically significantly associated with waist circumference (OR: 1.10 (1.03-1.17)), current smoking (OR: 2.54 (1.10-5.84)), and HDL-C (OR: 1.03 (1.00-1.06)).
CONCLUSION
The results of the study show that higher waist circumference is associated with more degraded TBS than BMD in both men and women. Years passed since menopause and current smoking, respectively in women and men, were associated with more degraded TBS. Considering TBS values in older individuals with higher waist circumference, or a history of smoking despite normal BMDs might help more accurate assessment of bone health. However, further studies are required to confirm the benefit.

Identifiants

pubmed: 34315430
doi: 10.1186/s12877-021-02375-8
pii: 10.1186/s12877-021-02375-8
pmc: PMC8314528
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

444

Informations de copyright

© 2021. The Author(s).

Références

Endocrine. 2016 Nov;54(2):342-347
pubmed: 26815904
Bone. 2018 Aug;113:161-168
pubmed: 29802962
Diabetes Res Clin Pract. 2019 Sep;155:107790
pubmed: 31325536
Osteoporos Int. 2018 Mar;29(3):733-739
pubmed: 29290026
BMC Musculoskelet Disord. 2016 Jan 13;17:17
pubmed: 26757709
J Bone Miner Res. 2019 Dec;34(12):2229-2237
pubmed: 31419331
Osteoporos Sarcopenia. 2017 Jun;3(2):98-103
pubmed: 30775511
J Bone Miner Res. 2016 May;31(5):940-8
pubmed: 26498132
Menopause. 2019 Oct;26(10):1166-1170
pubmed: 31188287
Calcif Tissue Int. 2015 Jun;96(6):500-9
pubmed: 25796374
Med Sci Sports Exerc. 2003 Jul;35(7):1196-202
pubmed: 12840642
J Bone Miner Res. 1999 Sep;14(9):1622-7
pubmed: 10469292
Bone. 2004 Jan;34(1):195-202
pubmed: 14751578
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
Osteoporos Int. 2017 Mar;28(3):909-915
pubmed: 27900426
J Clin Densitom. 2015 Jul-Sep;18(3):309-30
pubmed: 26277849
Osteoporos Int. 2017 Oct;28(10):2843-2851
pubmed: 28647804
Endokrynol Pol. 2019;70(4):350-356
pubmed: 31489959
BMJ Open. 2017 Aug 4;7(8):e013606
pubmed: 28780537
Sci Rep. 2016 Apr 26;6:24935
pubmed: 27112305
Int J Clin Pract. 2019 May;73(5):e13347
pubmed: 30912212
J Clin Densitom. 2019 Apr - Jun;22(2):266-271
pubmed: 28712983
Medicine (Baltimore). 2017 Nov;96(45):e8661
pubmed: 29137106
PLoS One. 2019 Feb 1;14(2):e0209777
pubmed: 30707701
Am J Clin Nutr. 2004 May;79(5):921S-930S
pubmed: 15113740
Bone. 2017 Nov;104:66-72
pubmed: 28159710
Curr Med Res Opin. 2005 Jul;21(7):1049-56
pubmed: 16004672
Osteoporos Int. 2019 Oct;30(10):2079-2085
pubmed: 31214749
J Clin Densitom. 2017 Apr - Jun;20(2):233-238
pubmed: 28034592
J Clin Endocrinol Metab. 2005 May;90(5):2787-93
pubmed: 15728213
BMJ Open. 2015 Dec 16;5(12):e009597
pubmed: 26674503
Arch Osteoporos. 2019 May 11;14(1):52
pubmed: 31079228
Eur Spine J. 2016 Nov;25(11):3432-3438
pubmed: 26014806

Auteurs

Nekoo Panahi (N)

Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Afshin Ostovar (A)

Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Noushin Fahimfar (N)

Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Hamid Reza Aghaei Meybodi (HR)

Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Safoora Gharibzadeh (S)

Department of Epidemiology and Biostatistics, Pasteur Institute of Iran, Tehran, Iran.

Babak Arjmand (B)

Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mahnaz Sanjari (M)

Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Kazem Khalagi (K)

Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Ramin Heshmat (R)

Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Iraj Nabipour (I)

The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.

Akbar Soltani (A)

Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Bagher Larijani (B)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. emrc@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH